181 / 204
Notes To The
Financial Statements
As at 31 March 2019
35. Financial instruments (cont’d.)
(a) Classification of financial instruments (cont’d.)
The following table presents the Group’s and the Company’s other financial assets that are measured at
fair value as at 31 March 2019 and 31 March 2018. (cont’d.)
Group
Company
Date of
Level 3
Level 3
Valuation
RM’000
RM’000
As at 31 March 2019
Assets disclosed at fair value:
Investment properties (Note 13)
31 March 2019
62,650
51,000
Assets measured at fair value:
Biological assets (Note 18)
31 March 2019
1,019
-
Assets measured at fair value:
Reeemable preference shares (Note 15 (g))
31 March 2019
-
35,400
As at 31 March 2018
Assets disclosed at fair value:
Investment properties (Note 13)
31 March 2018
61,805
50,005
Assets measured at fair value:
Biological assets (Note 18)
31 March 2018
2,145
-
(b) The financial instruments of the Group and of the Company as at the reporting date are categorised into
the following classes:
Group
Company
2019
2018
2019
2018
RM’000
RM’000
RM’000
RM’000
(i) Financial assets measured at
amortised cost
Trade receivables
83,209
103,530
528
445
Other receivables excluding tax
recoverable, GST input tax and
prepayments (Note 17)
6,697
4,479
194
198
Amount due from related companies
(Note 20)
525
28
13,438
45,174
Cash and bank balances (Note 22)
57,855
165,596
854
3,316
Total financial assets measured at
amortised cost
148,286
273,633
15,014
49,133
financial
statements
177